908 DevicesMASS -2.19%70 3-Year ROIIC % is 35.86 as of Dec. 2025. GuruFocus rates MASS with a GF Score™ of 70/100 and a GF Value™ of $6.95 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 799 Medical Devices & Instruments companies, 908 Devices ranks better than 78.97% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
908 Devices's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 35.86%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for 908 Devices's 3-Year ROIIC % or its related term are showing as below:
MASS's 3-Year ROIIC % is ranked better than 78.97% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: 1.78
vs MASS: 35.86
908 Devices (NAS:MASS) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
908 Devices 3-Year ROIIC % Related Terms
908 Devices 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for 908 Devices's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MASS vs ELMD, CATX, SGHT: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, 908 Devices's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
908 Devices 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 908 Devices's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where 908 Devices's 3-Year ROIIC % falls into.
908 Devices's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -25.62864 (Dec. 2025) - -35.382 (Dec. 2022) )
/
( 76.029 (Dec. 2025) - 48.83 (Dec. 2022) )
=
9.75336
/
27.199
=
35.86%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
908 Devices (MASS) has a 3-Year ROIIC % of 35.86 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on 908 Devices and its competitors. According to the industry distribution chart, 908 Devices ranks #168 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 21%.
Is 908 Devices' 3-Year ROIIC % too high?
908 Devices' current 3-Year ROIIC % is 35.86. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.78. 908 Devices' value of 35.86 is 1914.6% above this industry median. Based on the distribution chart, 908 Devices ranks #168 out of 799 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, 908 Devices has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 908 Devices' 3-Year ROIIC % compare to ELMD and CATX?
According to the Medical Devices & Instruments industry distribution chart, 908 Devices ranks #168 out of 799 companies for 3-Year ROIIC %. This places 908 Devices in the top 21% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.78. 908 Devices' value of 35.86 is 1914.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.78, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 908 Devices's current 3-Year ROIIC % of 35.86 is 1914.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on 908 Devices and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 908 Devices's current 3-Year ROIIC % is 35.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 908 Devices stock overvalued right now?
Based on GuruFocus' analysis, 908 Devices (MASS) is currently considered Modestly Overvalued. The stock's GF Value™ is $6.95, compared to a current price of $8.68 — trading 24.9% above its estimated fair value. The current 3-Year ROIIC % is 35.86 and 1914.6% above the Medical Devices & Instruments industry median of 1.78. 908 Devices' overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For 908 Devices (MASS), the current 3-Year ROIIC % is 35.86 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 908 Devices (MASS) Overvalued in 2026?
Based on GuruFocus' analysis, 908 Devices stock appears to be overvalued.
The current stock price of $8.68 is trading 24.9% above its estimated GF Value™ of $6.95.
GuruFocus considers 908 Devices to be Modestly Overvalued.
Key valuation signals for MASS:
3-Year ROIIC %: 35.86
GF Value™: $6.95 vs. price of $8.68 (24.9% above fair value)
Industry Position: 1914.6% above the Medical Devices & Instruments median (#168 of 799)
No single metric tells the full story. See the MASS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
70GF Score
Get the complete analysis for MASS
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MASS has been successfully added to your 
